444 related articles for article (PubMed ID: 24256214)
1. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
[TBL] [Abstract][Full Text] [Related]
2. Dual ligands modified double targeted nano-system for liver targeted gene delivery.
Jing F; Li J; Liu D; Wang C; Sui Z
Pharm Biol; 2013 May; 51(5):643-9. PubMed ID: 23527957
[TBL] [Abstract][Full Text] [Related]
3. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.
Wang W; Zhou F; Ge L; Liu X; Kong F
Int J Nanomedicine; 2012; 7():2513-22. PubMed ID: 22679364
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
5. A promising targeted gene delivery system: folate-modified dexamethasone-conjugated solid lipid nanoparticles.
Wang W; Zhou F; Ge L; Liu X; Kong F
Pharm Biol; 2014 Aug; 52(8):1039-44. PubMed ID: 24611745
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy.
Han Y; Zhang P; Chen Y; Sun J; Kong F
Int J Mol Med; 2014 Jul; 34(1):191-6. PubMed ID: 24804644
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
[TBL] [Abstract][Full Text] [Related]
8. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
Wu G; Wang Z; Bian X; Du X; Wei C
Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
[TBL] [Abstract][Full Text] [Related]
9. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
Zhang P; Zhang Z; Yang Y; Li Y
Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
[TBL] [Abstract][Full Text] [Related]
10. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
[TBL] [Abstract][Full Text] [Related]
12. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Zhang S; Tang C; Yin C
Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
[TBL] [Abstract][Full Text] [Related]
13. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.
Liang B; He ML; Xiao ZP; Li Y; Chan CY; Kung HF; Shuai XT; Peng Y
Biochem Biophys Res Commun; 2008 Mar; 367(4):874-80. PubMed ID: 18201560
[TBL] [Abstract][Full Text] [Related]
15. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
16. Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes.
Omata D; Negishi Y; Hagiwara S; Yamamura S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
J Drug Target; 2012 May; 20(4):355-63. PubMed ID: 22332850
[TBL] [Abstract][Full Text] [Related]
17. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.
Cao D; Tian S; Huang H; Chen J; Pan S
Mol Pharm; 2015 Jan; 12(1):240-52. PubMed ID: 25514347
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery.
Chan P; Kurisawa M; Chung JE; Yang YY
Biomaterials; 2007 Jan; 28(3):540-9. PubMed ID: 16999995
[TBL] [Abstract][Full Text] [Related]
19. Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
Tang Z; Li D; Sun H; Guo X; Chen Y; Zhou S
Biomaterials; 2014 Sep; 35(27):8015-27. PubMed ID: 24947231
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
Cheng H; Zhu JL; Zeng X; Jing Y; Zhang XZ; Zhuo RX
Bioconjug Chem; 2009 Mar; 20(3):481-7. PubMed ID: 19191579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
